We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Science & Health

Switching to Edibles Could Alleviate Cannabis Hyperemesis Syndrome – Study

Published: Jun 11, 2019   

Complete the form below and we will email you a PDF version of "Switching to Edibles Could Alleviate Cannabis Hyperemesis Syndrome – Study"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Switching to Edibles Could Alleviate Cannabis Hyperemesis Syndrome – Study

The medical use of cannabis is growing. Medical marijuana may improve symptoms including pain and anorexia. While it may improve nausea and vomiting, it can rarely cause a hyperemesis syndrome with chronic use. Because this is a rare syndrome, case reports are important. 

A new case study has surprisingly shown that stopping cannabis use may not be necessary to alleviate cannabis hyperemesis syndrome. The case study and a review of the current literature on cannabis hyperemesis syndrome are published in the Journal of Palliative Medicine

Ileana Howard, MD, of the University of Washington presented the unique example of a patient with amyotrophic lateral sclerosis (ALS) receiving palliative care who was able to overcome the effects of nausea and vomiting linked to chronic cannabis use by markedly decreasing, but not discontinuing the use of cannabis. 

In the article entitled Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review, Dr Howard reported that the patient stopped using inhaled concentrated cannabis extracts, but continued to use oral whole plant-based edible cannabis, which eliminated the cannabis hyperemesis syndrome while sustaining the beneficial effects on other symptoms. This paper and the comprehensive literature review illustrate the challenges in diagnosis, assessment, and management of these patients by clinicians.

Charles F. von Gunten, MD, PhD, editor-in-chief of the Journal of Palliative Medicine and vice president of medical affairs for the OhioHealth system states: “This case study adds to our clinical ability to respond to rare adverse effects of medical cannabis use. Given the meteoric rise in the medical use of marijuana across the US and around the world, it is essential to disseminate these clinical observations.”


This article has been republished from materials provided by Mary Ann Liebert, Inc. Note: material may have been edited for length and content. For further information, please contact the cited source.


Reference 

Ileana Howard. Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review. The Journal of Palliative Medicine, 2019. 

 

Like what you just read? You can find similar content on the topic tags shown below.

Cultivation Extraction & Processing Science & Health Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement